데이터를 보충하는 중입니다. 잠시 후 페이지를 새로 고치면 최신 내용을 볼 수 있습니다
101861-63-6O=C(O)CCc1c(C(=O)O)[nH]c2cc(Cl)cc(Cl)c12KNBSYZNKEAWABY-UHFFFAOYSA-N101861-63-6、130798-51-5DTXSID901356859CHEMBL31344안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.
개요NMDA receptors are neuroreceptors that have binding sites for glycine or D-serine as well as L-glutamate. MDL 29951 is an antagonist of NMDA receptors with high affinity for the glycine binding site (Ki = 140 nM). It is functional both in vitro and in vivo. MDL 29951 blocks NMDA receptor-dependent convulsions in audiogenic seizure-susceptible DBA/2J mice. It is used to evaluate the role of the glycine site of the NMDA receptor in neurological signaling. MDL 29951 is also an agonist of the G protein-coupled receptor GPR17 (EC50 values range from 7 nM to 6 μM, depending on the assay). GPR17 is thought to be involved in oligodendrocyte differentiation and myelin formation/repair.
용도MDL 29951 is an allosteric inhibitor of the enzyme fructose 1,6-bisphosphatase.
현재 필터 조건에 해당하는 반응 기록이 없습니다.
불러오는 중…